The pharmaceutical sector, often known as "Big Pharma", is facing a rising tide of mass torts, prompted by its alleged role in harmful drug effects, inadequate warnings of severe risks, and deceptive marketing. These matrix actions, sparked by a single harmful conduct, underscore dire need for stricter industry monitoring. The opioid crisis personifies these allegations, with companies accused of not disclosing addiction risks linked with these drugs. Plus, manufacturers' failure to reveal serious side effects further darkens the scenario. Big Pharma’s monopoly-like ability to manipulate patents escalates drug prices, hindering generic competition. Demanding justice becomes challenging against such corporations' massive resources, stressing industry reform imperative. This should strive for better transparency, stricter regulation, and regulatory authority empowerment to hold the industry answerable. Realizing a future with a transparent, accountable pharmaceutical sector, genuinely dedicated to human health improvement, warrants a joint effort from legal systems, regulatory bodies, and the public.
Full article here: https://medium.com/@lawsuithelpdesk/unmasking-the-dark-side-of-big-pharma-the-shocking-mass-torts-revelations-you-need-to-know-now-df26c88cf85d